Literature DB >> 15591456

Sialyl Lewisa expression as a predictor of the prognosis of colon carcinoma patients in a prospective randomized clinical trial.

Takanori Matsui1, Hiroshi Kojima, Harumi Suzuki, Hiroshi Hamajima, Hiroaki Nakazato, Katsuki Ito, Akimasa Nakao, Junichi Sakamoto.   

Abstract

BACKGROUND: The metastatic potential of tumors is dependent on the cell to cell adhesion by cell surface carbohydrate antigens. Thus, expression of sialyl Lewis(a), which is one of the important molecules of cell surface carbohydrates, may serve as a prognostic marker of aggressive and metastasizing tumor growth. However, the prognostic value of sialyl Lewis(a) expression in colon cancer is still controversial.
METHODS: In this study, we investigated the expression of sialyl Lewis(a) antigen in 233 colon cancer specimens from patients who were registered in a prospective adjuvant immunochemotherapy clinical trial. The clinical course and the prognosis of the patients were evaluated after all the immunohistochemical analyses had been performed.
RESULTS: Sialyl Lewis(a) expression levels were correlated with both overall survival (P = 0.0006) and disease-free survival (P = 0.004) in all patients with the log-rank test. This result could be assumed to have been influenced by the difference in the metastatic preponderance in a high versus low sialyl Lewis(a) expression in the tumor cells.
CONCLUSION: This prospective study in a randomized controlled trial suggests that sialyl Lewis(a) expression levels may serve as an indicator of the metastatic potential of colon cancer cells, which would strongly predict the prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591456     DOI: 10.1093/jjco/hyh110

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  7 in total

1.  Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways.

Authors:  Polina Weitzenfeld; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

2.  Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity.

Authors:  Ritsuko Sawada; Shu-Man Sun; Xiaohong Wu; Feng Hong; Govind Ragupathi; Philip O Livingston; Wolfgang W Scholz
Journal:  Clin Cancer Res       Date:  2011-02-22       Impact factor: 12.531

3.  Associated expression of α2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer.

Authors:  Takaharu Fukasawa; Takayuki Asao; Hayato Yamauchi; Munenori Ide; Yuichi Tabe; Takaaki Fujii; Satoru Yamaguchi; Soichi Tsutsumi; Shin Yazawa; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2012-03-08       Impact factor: 2.549

Review 4.  Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Authors:  Thomas Dittmar; Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2007-09-08       Impact factor: 5.150

Review 5.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

6.  Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a.

Authors:  Vishwanath B Chachadi; Mohamed F Ali; Pi-Wan Cheng
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

Review 7.  Tumor-Induced Local and Systemic Impact on Blood Vessel Function.

Authors:  J Cedervall; A Dimberg; A-K Olsson
Journal:  Mediators Inflamm       Date:  2015-12-07       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.